Specialty Pharmacy

Ixazomib is an oral proteasome inhibitor used in combination with lenalidomide and dexamethasone.

Patients on Medicaid more likely to have HCV infection and much more likely to be denied coverage.

Top stories of the week on Specialty Pharmacy Times.

Study suggests increasing oxidative stress through with pro-oxidants may prevent metastasis.

Quality of life after surgical treatment is an important part of recovery.

A majority of life sciences companies are planning on acquisitions and are targeting companies with a personalized medicine focus.

Legislators evaluate negotiation and pricing practices in the pharmacy industry.

Women with type 2 diabetes have greater difficulty with exercise than those without the condition.

Specialty drugs for chronic, rare, and genetic diseases are forecast to drive a $298 billion increase in brand spending.

Treatment helps reduce infection risk from low white blood cell count in cancer patients receiving chemotherapy.

Molecular mechanisms behind acute myeloid leukemia may offer a new target for drug development.

Biologic pathway associated with neural stem cells can affect the growth of some cancers.

Vitamin D deficiency may impact immune recovery in patients with HIV.

The action by NICE highlights discussion on both sides of the Atlantic about the cost of PCSK9 inhibitors, which lower LDL cholesterol.

Being a pharmacist in today's world means more than just filling prescriptions. Building and maintaining patient relationships should be the No. 1 priority for practicing pharmacists.

Novel drug shows promise in chronic lymphocytic leukemia and non-Hodgkin lymphoma refractory or resistant to current chemotherapies.

Atheer Kaddis, PharmD, senior vice president of Business Development and Sales at Diplomat, discusses retail network services.

FDA requests a more thorough review of rociletinib from ongoing trial.

B cell depletion therapy decreases new disease activity in people with relapsing-remitting MS.

Number of infected people is projected to drop below 1 million by 2020, but with substantial HCV disease and death burden.

Significant weight loss found to reduce disease burden in psoriatic arthritis patients.

States in the south and southwest regions of the country tend to have more uninsured residents, while northern states typically have more insured residents.

Opdivo shows extended overall survival and fewer adverse events in patients with RCC compared with Afinitor.

Antiretroviral drug interactions now included due to high prevalence of HIV coinfection among patients with hepatitis C virus.

Specific vaccine-induced immune responses correlate with reduced HIV infection.

Express Scripts removes specialty pharmacy Linden Care from its network.

Caregivers should be mindful of COPD patient-reported symptoms that may lead to hospitalization.

Daratumumab is a single agent for multiple myeloma in patients who previously received at least 3 lines of therapy.

Study finds many silver plans have higher out-of-pocket costs for most the commonly prescribed HIV treatments.

Approval sought for Imbruvica combination for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.